序号 |
标题 |
次数 |
作者 |
发布时间 |
85231 |
Cu-p-SCN-Bn-DOTA-KLH;双功能螯合剂DOTA偶联KLH抗体 |
186 |
wyh |
2024-11-27 |
85232 |
DOTA-Bz-RGD tetramer;DOTA偶联苄基修饰RGD四聚体 |
116 |
wyh |
2024-11-27 |
85233 |
DOTA-sst2-ANT;DOTA偶联受体拮抗剂 |
83 |
wyh |
2024-11-27 |
85234 |
二肽联接的二倍体造影剂配体 ;{HO-GK-(DOTA)2} |
110 |
wyh |
2024-11-27 |
85235 |
DOTA-Cys-ZHER2:342;大环DOTA修饰Z HER2:342-半胱氨酸 |
114 |
wyh |
2024-11-27 |
85236 |
DOTA-[Tyr3]-Octreotide 奥曲肽PET探针前体 |
143 |
zcy |
2024-11-26 |
85237 |
Gd-DOTA-HCBP;用于核磁共振成像(MRI)的多肽探针 |
163 |
zcy |
2024-11-26 |
85238 |
204318-14-9,Edotreotide,奥曲肽的多肽,DOTA大环化合物 |
116 |
zcy |
2024-11-26 |
85239 |
1610950-41-8,DOTA-甲基四嗪 |
126 |
zcy |
2024-11-26 |
85240 |
1189194-65-7,DOTA-CH2-Alkynyl (TFA salt) |
86 |
zcy |
2024-11-26 |
85241 |
177943-89-4,DOTATATE,DOTA-3-酪氨酰基-奥曲肽 |
118 |
zcy |
2024-11-26 |
85242 |
DOTA-Glu(cyclo(Arg-Gly-Asp-DPhe-Lys))2;肽类配体 |
153 |
zcy |
2024-11-26 |
85243 |
DOTA-Octreotide,DOTA-奥曲肽 |
111 |
zcy |
2024-11-26 |
85244 |
DOTA-(酪氨酸3)-奥曲肽,DOTA-[Tyr3]-Octreotide,204318-14-9 |
126 |
zcy |
2024-11-26 |
85245 |
PSMA I&T,2192281-54-0 |
108 |
zcy |
2024-11-26 |
85246 |
DOTA-E[cyclo(RGDfK)2] 螯合物前体多肽 |
95 |
zcy |
2024-11-26 |
85247 |
204318-14-9,DOTA-(酪氨酸3)-奥曲肽 |
87 |
zcy |
2024-11-26 |
85248 |
大环配体奥曲肽,Dotatate,DOTA-奥曲肽 |
142 |
zcy |
2024-11-26 |
85249 |
NOTA-8-AOC-BBN(7-14)NH2 ;1,4,7-三氮杂环壬烷-1,4,7-三乙酸-8-氨基辛酸-铃蟾肽 |
153 |
kx |
2024-11-26 |
85250 |
NOTA-Arg-Gly-Asp , NOTA-RGD ,环状螯合剂NOTA偶联多肽RGD |
172 |
kx |
2024-11-26 |
85251 |
NOTA-糖N-乙酰神经氨酸 ,NOTA-Neu5Ac |
122 |
kx |
2024-11-26 |
85252 |
DOTA-[Tyr3]-Octreotide(CAS:204318-14-9),DOTA-(酪氨酸3)-奥曲肽,依多曲肽 |
159 |
zcy |
2024-11-26 |
85253 |
DOTA-3-酪氨酰基-奥曲肽(DOTA-3-tyrosinyl-octreotide) |
108 |
zcy |
2024-11-26 |
85254 |
NOTA-RGD-GE11 ,异二聚体肽缀合NOTA大环配体 |
146 |
kx |
2024-11-26 |
85255 |
DOTA-3-酪氨酰基-奥曲肽,DOTA-(Tyr3)-Octreotate |
111 |
zcy |
2024-11-26 |
85256 |
NOTA-c[KNGRE]-NH2肽 , NOTA修饰c[KNGRE]-NH2肽 |
178 |
kx |
2024-11-26 |
85257 |
DOTA-Ala-Ala-COOH,DOTA-丙氨酸-丙氨酸-羧酸 |
93 |
zcy |
2024-11-26 |
85258 |
NOTA-RGD-GE11, NOTA-RGD-GE11异源二聚肽 |
84 |
kx |
2024-11-26 |
85259 |
DOTA-p-NH2-Bn-Biotin,180978-54-5,DOTA-生物素-肌氨酸 |
104 |
zcy |
2024-11-26 |
85260 |
NOTA-ALT-836-Fab, NOTA偶联ALT-836的Fab片段 |
137 |
kx |
2024-11-26 |
85261 |
C13-多肽;C13(碳-13)同位素标记的多肽 |
231 |
zcy |
2024-11-26 |
85262 |
DOTATATE,177943-89-4,放射性示踪剂 |
120 |
zcy |
2024-11-26 |
85263 |
1,4,7-三氮杂环壬烷-1,4,7-三乙酸(NOTA)螯合寡核苷酸透明质酸(HA)四糖和六糖缀合物 |
218 |
kx |
2024-11-26 |
85264 |
DOTA-RGD,DOTA-cRGDfK,螯合剂修饰多肽 |
137 |
zcy |
2024-11-26 |
85265 |
NOTA-(FHT)2 , FHT肽序列偶联NOTA双功能螯合剂 |
102 |
kx |
2024-11-26 |
85266 |
DOTATATE;DOTA-octreotide;放射性示踪剂 |
125 |
zcy |
2024-11-26 |
85267 |
1201415-84-0,1180007-00-4,DOTA-Lys-Cys-COOH |
84 |
zcy |
2024-11-26 |
85268 |
619300-53-7,DOTA NOC acetate |
160 |
zcy |
2024-11-26 |
85269 |
1306310-00-8,DOTA-Gly-Asp-Tyr-Met-Gly-Trp-Met-Asp-Phe-NH2 |
99 |
zcy |
2024-11-26 |
85270 |
DOTA-NT , DOTA修饰神经降压素受体(NTRs) |
409 |
kx |
2024-11-26 |
85271 |
大环螯合物479081-06-6,DOTA-(COOt-Bu)3-NHFmoc-Lys |
117 |
zcy |
2024-11-26 |
85272 |
NOTA-Ile-Phe-Leu–Leu-Trp-Gln-Arg ,7聚体肽iflwqr偶联NOTA大环配体 |
140 |
kx |
2024-11-26 |
85273 |
DOTA-YHWYGYTPQNVI 大环化合物-多肽 |
101 |
zcy |
2024-11-26 |
85274 |
NOTA-cys(pHLIP ) , NOTA衍生的pH(低)插入肽(pHLIP) |
311 |
kx |
2024-11-26 |
85275 |
放射显影多肽DOTA-JR-11,CAS:1039726-31-2 |
109 |
zcy |
2024-11-26 |